Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/1/1999


1.		Phase III Randomized Double-Blind Trial of Mifepristone vs Placebo for Unresectable Meningioma (Summary Last Modified 10/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-9005 E-S9005, SWOG-9005

Last Modified: 9/1/1994


2.		Phase II Study of Mifepristone (RU486) in Women with Hormone-Responsive Metastatic Breast Cancer (Summary Last Modified 09/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								LBMMC-05193 NCI-V94-0462

Last Modified: 7/1/1997


3.		Phase II Study of Mifepristone in Persistent or Recurrent Epithelial Ovarian Carcinoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				Other				CH-RP-9368 NCI-V95-0711

Last Modified: 5/1/1990


4.		Phase II Study of the Antiprogestational Agent RU486 in Patients with Unresectable Meningioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								LAC-USC-6M871 NCI-V87-0233

Last Modified: 1/1/1995


5.		Phase II Study of the Progesterone Antagonist Mifepristone in Postmenopausal Patients with Stage IV Breast Cancer (Summary Last Modified 01/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				postmenopausal								CAN-NCIC-IND73 NCI-V92-0088, IND73


6.		Mifepristone (RU-486) in Androgen Independent Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				04-249 NCT00140478

Last Modified: 9/3/2008 First Published: 4/2/2007


7.		Phase II Study of Mifepristone in Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				GOG-0170K GOG-0170K, NCT00459290


8.		Mifepristone for Patients With Endometrial Cancer and LGESS

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Not specified				Other				ID01-212 NCT00505739

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute